Alliance centralized procurement "speed-up and expansion" hammer!

In order to implement the requirements of the National Convention on “speeding up and expanding coverage” for centralized procurement with volume, the National Medical Insurance Administration has recently made a unified deployment and coordination of the centralized procurement of local alliances, and has clarified the leading units and procurement categories of the centralized procurement of the alliance to be promoted in 2022.

From the perspective of the key varieties promoted by the centralized procurement of various alliances, drugs have been extended from chemical drugs to traditional Chinese medicines, and the variety of medical equipment has been expanded, involving oral implants, electrophysiology and endoscopic staplers, new crown-related testing reagents and consumables, liver function Biochemical reagents, etc.

Identify key promotion alliances and lead provinces

Traditional Chinese medicine is one of the focus, and the new "dark horse" is here!

It is understood that according to the work arrangement, the centralized procurement of the alliance to be promoted in 2022 includes: Hubei-led Chinese patent medicine alliance procurement, Sichuan-led oral implant alliance procurement, these two alliances are expected to participate in most provinces

In fact, the accelerated promotion of alliance procurement has long been expected

In terms of medicines, traditional Chinese medicine is obviously the focus of the alliance's centralized procurement, and Chinese patent medicines, Chinese medicine decoction pieces and formula granules will all be included

From the perspective of the industry, Chinese patent medicine products will be rapidly differentiated, and centralized procurement will not only test the production capacity of pharmaceutical companies, but also test the cost control ability and price reduction flexibility of pharmaceutical companies

Variety of instruments 

Collect or last for a long time

From the perspective of centralized procurement, in addition to national centralized procurement, alliance centralized procurement has become the mainstream

Previously, the relevant person in charge of the National Medical Insurance Bureau said that the current main structure is the recruitment of national organizations and inter-provincial alliances, and these two patterns remain unchanged

It is worth noting that more medical devices will also be included in the centralized collection varieties of the alliance
.
"Because there are many types of medical device products, it is roughly estimated that the number of varieties currently included in centralized procurement is less than 2%.
It is expected that the promotion time of centralized procurement will last for a long time
.
" Wang Qiang, a senior medical device marketing expert, told reporters that from the key categories promoted this year, Look, in addition to the popular oral implants, most of the low-end staplers have been collected, and now we are starting to advance to the high-end endoscopic staplers
.
Imported electrophysiology equipment accounts for 85%, and the domestically produced premium capacity is low.
This variety is usually not included in the centralized procurement.
It should be based on a test of the centralized procurement of high-end, high-priced high-value consumables
.
The centralized collection of liver function biochemical reagents led by Jiangxi is relatively new, and the choice of Jiangxi to lead also has a pilot meaning
.
The ultrasonic cutter head and pre-filled catheter irrigator purchased by the 16-province alliance led by Guangdong will soon be implemented
.

Under the promotion of national procurement + alliance centralized procurement, the medical device market will rapidly evolve
.
Wang Qiang believes, "There will be four main trends: some imported brands will be forced to accelerate the process of comprehensive localization and establish production bases in China; second- and second-tier imported brands whose prices are difficult to reduce will be eliminated; domestic enterprises will highlight cost leadership and cost-effective advantages; medical The cooperation between machinery companies and large commercial distribution groups will become closer and closer
.
"

Text editor: Yu Rujin

Format editor: Chen Lina